Company Overview
Aché is a leading Brazilian pharmaceutical group, ranked #1 in the Rx market. AS012 (vitiligo) and ACH36 (PTSD) are the company’s most promising NCE’s in clinical development. Aché also offers a variety of “me better” products, based on differentiated technology platforms.